Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease

Journal of Neuroscience

Volumn 31, Issue 10, 2011, Pages 3926-3934

  Perez Cruz, Claudia ^a   Nolte, Marc W ^a   Van Gaalen, Marcel M ^a   Rustay, Nathan R ^b   Termont, Annelies ^c   Tanghe, An ^c   Kirchhoff, Frank ^d,e   Ebert, Ulrich ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

^b GPRD Neuroscience and Anesthesia Development   (United States)

^c NV reMYND   (Belgium)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPAL CA1 REGION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SPATIAL MEMORY; SYNAPSE; TRANSGENIC MOUSE; WILD TYPE;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; CA1 REGION, HIPPOCAMPAL; CONDITIONING, CLASSICAL; CYTOSKELETAL PROTEINS; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; FEAR; FREEZING REACTION, CATALEPTIC; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PYRAMIDAL CELLS; SOMATOSTATIN;

EID: 79952401018     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6142-10.2011     Document Type: Article

References (56)

1. Abraham WC, Wickens JR (1991) Heterosynaptic long-term depression is facilitated by blockade of inhibition in area CA1 of the hippocampus. Brain Res 546:336-340.
2. Arai A, Black J, Lynch G (1994) Origins of the variations in long-term potentiation between synapses in the basal versus apical dendrites of hippocampal neurons. Hippocampus 4:1-9. (Pubitemid 24168375)
3. Arendt T (2001) Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int J Dev Neurosci 19:231-245.
4. Arendt T, Brückner MK, Gertz HJ, Marcova L (1998) Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83:991-1002. (Pubitemid 28114194)
5. Bonhoeffer T, Yuste R (2002) Spine motility. Phenomenology, mechanisms, and function. Neuron 35:1019-1027.
6. Bramham CR, Worley PF, Moore MJ, Guzowski JF (2008) The immediate early gene Arc/Arg3.1: regulation, mechanisms, and function. J Neurosci 28:11760-11767.
7. Burgos-Ramos E, Hervás-Aguilar A, Aguado-Llera D, Puebla-Jiménez L, Hernández-Pinto AM, Barrios V, Arilla-Ferreiro E (2008) Somatostatin and Alzheimer's disease. Mol Cell Endocrinol 286:104-111.
8. Buxbaum JD, Thinakaran G, Koliatsos V, O'Callahan J, Slunt HH, Price DL, Sisodia SS (1998) Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci 18:9629-9637. (Pubitemid 28543744)
9. Calabrese B, Shaked GM, Tabarean IV, Braga J, Koo EH, Halpain S (2007) Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally secreted amyloid-beta protein. Mol Cell Neurosci 35:183-193. (Pubitemid 46843559)
10. Cheng HW, Rafols JA, Goshgarian HG, Anavi Y, Tong J, McNeill TH (1997) Differential spine loss and regrowth of striatal neurons following multiple forms of deafferentation: a Golgi study. Exp Neurol 147:287-298. (Pubitemid 27497291)
11. Cope DW, Maccaferri G, Márton LF, Roberts JD, Cobden PM, Somogyi P (2002) Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109:63-80. (Pubitemid 34088147)
12. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464. (Pubitemid 20149963)
13. Dodart JC, Mathis C, Saura J, Bales KR, Paul SM, Ungerer A (2000) Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice. Neurobiol Dis 7:71-85. (Pubitemid 30241204)
14. Gavilán MP, Revilla E, Pintado C, Castaño A, Vizuete ML, Moreno-González I, Baglietto-Vargas D, Sánchez-Varo R, Vitorica J, Gutiérrez A, Ruano D (2007) Molecular and cellular characterization of the age-related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons. J Neurochem 103:984-996. (Pubitemid 47568716)
15. Gibb R, Kolb B (1998) A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 79:1-4. (Pubitemid 28248234)
16. Gould E, Westlind-Danielsson A, Frankfurt M, McEwen BS (1990) Sex differences and thyroid hormone sensitivity of hippocampal pyramidal cells. J Neurosci 10:996-1003. (Pubitemid 20104795)
17. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
18. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE (2006) Earlyonset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103:5161-5166.
19. Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122:305-315. (Pubitemid 37410162)
20. Jinno S, Kosaka T (2000) Colocalization of parvalbumin and somatostatinlike immunoreactivity in the mouse hippocampus: quantitative analysis with optical dissector. J Comp Neurol 428:377-388.
21. Kokubo H, Kayed R, Glabe CG, Yamaguchi H (2005) Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res 1031:222-228. (Pubitemid 40093074)
22. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, KleinWL (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
23. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448-6453.
24. Lanz TA, Carter DB, Merchant KM (2003) Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13:246-253. (Pubitemid 36937206)
25. Lazarov O, Lee M, Peterson DA, Sisodia SS (2002) Evidence that synaptically released β-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22:9785-9793. (Pubitemid 35332862)
26. Leung LS, Shen B, Kaibara T (1992) Long-term potentiation induced by patterned stimulation of the commissural pathway to hippocampal CA1 region in freely moving rats. Neuroscience 48:63-74.
27. Lippa CF, Hamos JE, Pulaski-Salo D, DeGennaro LJ, Drachman DA (1992) Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 13:405-411.
28. Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P, Larson J, Condie BG, Guidotti A, Costa E (2001) Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploin-sufficient heterozygous reeler mouse. Proc Natl Acad Sci U S A 98:3477-3482. (Pubitemid 32220870)
29. Lonergan ME, Gafford GM, Jarome TJ, Helmstetter FJ (2010) Time-dependent expression of Arc and Zif268 after acquisition of fear conditioning. Neural Plast 2010:139891.
30. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246.
31. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866.
32. Miyashita T, Kubik S, Haghighi N, Steward O, Guzowski JF (2009) Rapid activation of plasticity-associated gene transcription in hippocampal neurons provides a mechanism for encoding of one-trial experience. J Neurosci 29:898-906.
33. Moechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483-6492. (Pubitemid 29111064)
34. Moser MB, Trommald M, Egeland T, Andersen P (1997) Spatial training in a complex environment and isolation alter the spine distribution differently in rat CA1 pyramidal cells. J Comp Neurol 380:373-381. (Pubitemid 27161327)
35. Nolte MW, Jongen-Rêlo AL, Meyer AH, Gross G, Schoemaker H, Ebert U (2008) Activity- and age-dependent alterations of Arc expression in the brain of Tg2576 mice. Soc Neurosci Abstr 34:441.1.
36. Parnavelas JG, Lynch G, Brecha N, Cotman CW, Globus A (1974) Spine loss an regrowth in hippocampus following deafferentation. Nature 248:71-73.
37. Pawelzik H, Hughes DI, Thomson AM (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin- positive interneurones in CA1 of the adult rat hippocampus. J Comp Neurol 443:346-367. (Pubitemid 34101318)
38. Paxinos G, Franklin KB (2001) The mouse brain in stereotaxic coordinates, Ed 2. Hong Kong: Academic.
39. Ramos B, Baglietto-Vargas D, del Rio JC, Moreno-Gonzalez I, Santa-Maria C, Jimenez S, Caballero C, Lopez-Tellez JF, Khan ZU, Ruano D, Gutierrez A, Vitorica J (2006) Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiol Aging 27:1658-1672. (Pubitemid 44363105)
40. Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE (2003) Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci U S A 100:4837-4842. (Pubitemid 36457815)
41. Santos HR, Cintra WM, Aracava Y, Maciel CM, Castro NG, Albuquerque EX (2004) Spine density and dendritic branching pattern of hippocampal CA1 pyramidal neurons in neonatal rats chronically exposed to the organophosphate paraoxon. Neurotoxicology 25:481-494. (Pubitemid 38283551)
42. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875. (Pubitemid 46438992)
43. Sprusston N, McBain C (2007) Structure and functional properties of hippocampal neurons. In: The hippocampus book (Andersen P, Morris R, Amaral D, Bliss T, O'Keefe J, eds), pp 133-188. New York: Oxford UP.
44. Su Y, Ni B (1998) Selective deposition of amyloid-beta protein in the entorhinal dentate projection of a transgenic mouse model of Alzheimer's disease. J Neurosci Res 53:177-186.
45. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56:933-944.
46. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK (2004) Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-3599. (Pubitemid 38481116)
47. Tanghe A, Termont A, Merchiers P, Schilling S, Demuth H, Scrocchi L, Van Leuven F, Griffioen G, Van Dooren T (2010) Pathological hallmarks, clinical parallels and value for drug testing in Alzheimer's disease of the APP[V717I] London transgenic mouse model. Int J Alzheimers Dis pii:417314.
48. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120:545-555.
49. Terry RD (1998) The cytoskeleton in Alzheimer disease. J Neural Transm Suppl 53:141-145.
50. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
51. Tzingounis AV, Nicoll RA (2006) Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 52:403-407. (Pubitemid 44667439)
52. Van Hoesen GW, Hyman BT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 83:445-457. (Pubitemid 20205298)
53. Vela J, Gutierrez A, Vitorica J, Ruano D (2003) Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 85:368-377. (Pubitemid 36438332)
54. von Bohlen und Halbach O, Zacher C, Gass P, Unsicker K (2006) Agerelated alterations in hippocampal spines and deficiencies in spatial memory in mice. J Neurosci Res 83:525-531. (Pubitemid 43384845)
55. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539. (Pubitemid 34288854)
56. Yuste R, Bonhoeffer T (2004) Genesis of dendritic spines: insights from ultrastructural and imaging studies. Nat Rev Neurosci 5:24-34. (Pubitemid 38076181)